The nature of small-airway obstruction in chronic obstructive pulmonary disease.

BACKGROUND Chronic obstructive pulmonary disease (COPD) is a major public health problem associated with long-term exposure to toxic gases and particles. We examined the evolution of the pathological effects of airway obstruction in patients with COPD. METHODS The small airways were assessed in surgically resected lung tissue from 159 patients--39 with stage 0 (at risk), 39 with stage 1, 22 with stage 2, 16 with stage 3, and 43 with stage 4 (very severe) COPD, according to the classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD). RESULTS The progression of COPD was strongly associated with an increase in the volume of tissue in the wall (P<0.001) and the accumulation of inflammatory mucous exudates in the lumen (P<0.001) of the small airways. The percentage of the airways that contained polymorphonuclear neutrophils (P<0.001), macrophages (P<0.001), CD4 cells (P=0.02), CD8 cells (P=0.038), B cells (P<0.001), and lymphoid aggregates containing follicles (P=0.003) and the absolute volume of B cells (P=0.03) and CD8 cells (P=0.02) also increased as COPD progressed. CONCLUSIONS Progression of COPD is associated with the accumulation of inflammatory mucous exudates in the lumen and infiltration of the wall by innate and adaptive inflammatory immune cells that form lymphoid follicles. These changes are coupled to a repair or remodeling process that thickens the walls of these airways.

[1]  Movat Hz.  Demonstration of all connective tissue elements in a single section; pentachrome stains. , 1955 .

[2]  H. Movat,et al.  Demonstration of all connective tissue elements in a single section; pentachrome stains. , 1955, A.M.A. archives of pathology.

[3]  E. Weibel.  Morphometry of the Human Lung , 1965, Springer Berlin Heidelberg.

[4]  E. Weibel.  Morphometry of the Human Lung , 1965, Springer Berlin Heidelberg.

[5]  P. Macklem,et al.  Significance of the relationship between lung recoil and maximum expiratory flow. , 1967, Journal of applied physiology.

[6]  J. Hogg,et al.  Site and nature of airway obstruction in chronic obstructive lung disease. , 1968, The New England journal of medicine.

[7]  W. Thurlbeck,et al.  The number and dimensions of small airways in emphysematous lungs. , 1972, The American journal of pathology.

[8]  J. Hogg,et al.  Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. , 1974, Laboratory investigation; a journal of technical methods and pathology.

[9]  C. Fletcher.  The Natural history of chronic bronchitis and emphysema: An eight-year study of early chronic obstructive lung disease in working men in London , 1976 .

[10]  N. Veall,et al.  INCREASED ALVEOLAR EPITHELIAL PERMEABILITY IN CIGARETTE SMOKERS , 1980, The Lancet.

[11]  L M Cruz-Orive,et al.  Sampling designs for stereology * , 1981, Journal of microscopy.

[12]  K. P. Van de Woestijne,et al.  Partitioning of pulmonary impedance in excised human and canine lungs. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[13]  J. Hogg,et al.  The detection of small airways disease. , 1984, The American review of respiratory disease.

[14]  J. Hogg,et al.  Reassessment of inflammation of airways in chronic bronchitis. , 1985, British medical journal.

[15]  J. Hogg,et al.  The use of the internal perimeter to compare airway size and to calculate smooth muscle shortening. , 1988, The American review of respiratory disease.

[16]  P. Paré,et al.  Small airway dimensions in smokers with obstruction to airflow. , 1990, The American review of respiratory disease.

[17]  J. Hogg,et al.  A model of the mechanics of airway narrowing. , 1990, Journal of applied physiology.

[18]  Annette J. Dobson,et al.  An introduction to generalized linear models , 1991 .

[19]  A. Abbas,et al.  Cellular and Molecular Immunology , 1991 .

[20]  T Takishima,et al.  Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. , 1992, Journal of applied physiology.

[21]  J. Hogg,et al.  Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. , 1992, The American review of respiratory disease.

[22]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[23]  Lloyd D. Fisher,et al.  Biostatistics: A Methodology for the Health Sciences , 1993 .

[24]  Lloyd D. Fisher,et al.  2. Biostatistics: A Methodology for the Health Sciences , 1994 .

[25]  W. Thurlbeck.  Lung structure and function in cigarette smokers. , 1994, Thorax.

[26]  J. Hogg,et al.  Lung structure and function in cigarette smokers. , 1994, Thorax.

[27]  L. Fabbri,et al.  Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. , 1996, American journal of respiratory and critical care medicine.

[28]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[29]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[30]  K P Whittall,et al.  Quantification of idiopathic pulmonary fibrosis using computed tomography and histology. , 1997, American journal of respiratory and critical care medicine.

[31]  L. Fabbri,et al.  Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. , 1997, American journal of respiratory and critical care medicine.

[32]  M. Lamm.  Interaction of antigens and antibodies at mucosal surfaces. , 1997, Annual review of microbiology.

[33]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[34]  Steven Piantadosi,et al.  Rationale and design of the national emphysema treatment trial: A prospective randomized trial of lung volume reduction surgery , 1999 .

[35]  Steven Piantadosi,et al.  Patients at high risk of death after lung-volume-reduction surgery. , 2001, The New England journal of medicine.

[36]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[37]  N. Mantis,et al.  Collaboration of epithelial cells with organized mucosal lymphoid tissues , 2001, Nature Immunology.

[38]  T. Murphy,et al.  Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review , 2001, Clinical Microbiology Reviews.

[39]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[40]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[41]  J. Vestbo,et al.  Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? , 2002, American journal of respiratory and critical care medicine.

[42]  M. Knowles,et al.  Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.

[43]  J. Lang.  An Introduction to Generalized Linear Models , 2003 .

[44]  P. Barnes.  Small airways in COPD. , 2004, The New England journal of medicine.

[45]  R. Pizov,et al.  A Randomized Trial Comparing Lung-Volume-Reduction Surgery with Medical Therapy for Severe Emphysema , 2004 .

[46]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .